Skip to content

PressReach

SEARCH icon
  • Investing
  • Featured
  • Market
  • Biotech
  • Oil & Gas
  • Mining
  • Gaming
  • Tech
  • Crypto
  • More
    • Health
    • Entertainment
    • Real Estate
    • Cannabis
    • ESG
    • Financial
    • Food & Beverage
    • Industrials
    • Travel & Hospitality
    • Trading Tips
    • Investing Videos
Search

SEARCH FOR AN ARTICLE

  • Investing
  • Featured
  • Market
  • Biotech
  • Oil & Gas
  • Mining
  • Gaming
  • Tech
  • Crypto
  • More
    • Health
    • Entertainment
    • Real Estate
    • Cannabis
    • ESG
    • Financial
    • Food & Beverage
    • Industrials
    • Travel & Hospitality
    • Trading Tips
    • Investing Videos

PressReach

icon

      HomeBiotech

      Biotech

      ADC Therapeutics Announces Completion of Enrollment of Phase 3 Confirmatory Clinical Trial of ZYNLONTA® in Combination with Rituximab in 2L+ Diffuse Large B-Cell Lymphoma
      Biotech

      ADC Therapeutics Announces Completion of Enrollment of Phase 3 Confirmatory Clinical Trial of ZYNLONTA® in Combination with Rituximab in 2L+ Diffuse Large B-Cell Lymphoma

      December 31, 2024
      Save The Giraffes spearheads breakthroughs in reproductive science in wild giraffes
      Biotech

      Save The Giraffes spearheads breakthroughs in reproductive science in wild giraffes

      December 31, 2024
      IDEAYA Biosciences Enters Exclusive License with Hengrui Pharma for SHR-4849, a Novel Phase 1 DLL3 Topo-I-Payload ADC Targeting SCLC and NET Solid Tumors
      Biotech

      IDEAYA Biosciences Enters Exclusive License with Hengrui Pharma for SHR-4849, a Novel Phase 1 DLL3 Topo-I-Payload ADC Targeting SCLC and NET Solid Tumors

      December 30, 2024
      Precigen Announces $79.0 Million Private Placement Offering of Convertible Preferred Stock
      Biotech

      Precigen Announces $79.0 Million Private Placement Offering of Convertible Preferred Stock

      December 28, 2024
      FDA Roundup: December 27, 2024
      Biotech

      FDA Roundup: December 27, 2024

      December 28, 2024
      FireflySci Inc. Announces Price Increase in Response to Proposed Import Tariffs
      Biotech

      FireflySci Inc. Announces Price Increase in Response to Proposed Import Tariffs

      December 27, 2024
      FDA Proposes Rule to Require Standardized Testing Methods for Detecting and Identifying Asbestos in Talc-Containing Cosmetic Products
      Biotech

      FDA Proposes Rule to Require Standardized Testing Methods for Detecting and Identifying Asbestos in Talc-Containing Cosmetic Products

      December 27, 2024
      AusperBio Secures $73 Million in Series B Financing to Advance Functional Cure for Chronic Hepatitis B
      Biotech

      AusperBio Secures $73 Million in Series B Financing to Advance Functional Cure for Chronic Hepatitis B

      December 27, 2024
      Global Multiomics Market Expected to Grow Rapidly, with 13.5% Annual Increase from 2024 to 2029
      Biotech

      Global Multiomics Market Expected to Grow Rapidly, with 13.5% Annual Increase from 2024 to 2029

      December 25, 2024
      Bio-Thera Solutions Partners with Tabuk Pharmaceuticals to Commercialize BAT2206, a Stelara® (Ustekinumab) Biosimilar in Saudi Arabia
      Biotech

      Bio-Thera Solutions Partners with Tabuk Pharmaceuticals to Commercialize BAT2206, a Stelara® (Ustekinumab) Biosimilar in Saudi Arabia

      December 25, 2024
      « 1 … 57 58 59 60 61 … 140 »

       

      LATEST NEWS

      • Health Sanofi Market Potential Boosted by Amvuttra Data

      PressReach

      All logos, trade names and/or trademarks, artwork and associated imagery are trademarks and/or copyright material of their respective owners.

      • Advertisers
      • Privacy Policy
      • Terms of Use
      • DMCA Policy
      • Disclaimer
      • Contact Us

      SUBSCRIBE

      To get email updates from PressReach.

      I want e-mail alerts, updates, and offers and agree to the PressReach privacy policy.

      Market Jar Media Inc. © 2026